Relationship of Electrocardiographic Left Ventricular Hypertrophy to the Presence of Diastolic Dysfunction

Annals of Noninvasive Electrocardiology

Volumn 19, Issue 6, 2014, Pages 552-560

  Krepp, Joseph M ^a   Lin, Fay ^a   Min, James K ^a   Devereux, Richard B ^a   Okin, Peter M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

diastolic dysfunction; electrocardiography; heart failure; hypertrophy

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DECELERATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ENLARGEMENT; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; ISOVOLUMIC RELAXATION TIME; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSIS; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK;

COHORT STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84937512169     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/anec.12166     Document Type: Article

References (41)

1. Bhatia RS, Tu JV, Lee DS, et al., Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
2. Halley CM, Houghtaling PL, Khalil MK, et al., Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 2011; 171: 1082-1087.
3. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al., Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
4. Lee DS, Wang TJ, Vasan RS,. Screening for ventricular remodeling. Curr Heart Fail Rep 2006; 3: 5-13.
5. Aljaroudi W, Alraies MC, Halley C, et al., Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 2012; 125: 782-788.
6. de Simone G, Gottdiener JS, Chinali M, et al., Left ventricular mass predicts heart failure not related to previous myocardial infarction: The Cardiovascular Health Study. Eur Heart J 2008; 29: 741-747.
7. Masugata H, Senda S, Inukai M, et al., Differences in left ventricular diastolic dysfunction between eccentric and concentric left ventricular hypertrophy in hypertensive patients with preserved systolic function. J Int Med Res 2011; 39: 772-779.
8. Zile MR, Baicu CF, Gaasch WH,. Diastolic heart failure-Abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959.
9. Levy D, Garrison RJ, Savage DD, et al., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
10. Kannel WB, Levy D, Cupples LA,. Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham Study. J Cardiovasc Pharmacol 1987; 10 (Suppl 6): S135-S140.
11. Wilcox JE, Rosenberg J, Vallakati A, et al., Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction. Am J Cardiol 2011; 108: 1760-1766.
12. Nagueh SF, Appleton CP, Gillebert TC, et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
13. Lang RM, Bierig M, Devereux RB, et al., Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
14. Quiñones MA, Otto CM, Stoddard M, et al., Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
15. Ommen SR, Nishimura RA, Appleton CP, et al., Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000; 102: 1788-1794.
16. Devereux RB, Alonso DR, Lutas EM, et al., Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57 (6): 450-458.
17. Report of committee on electrocardiography, American Heart Association. Recommendations for standardization of leads and of specifications for instruments in electrocardiography and vector cardiography. Circulation 1967; 35: 583-602.
18. Casale PN, Devereux RB, Alonso DR, et al., Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation 1987; 75: 565-572.
19. Molloy TJ, Okin PM, Devereux RB, et al., Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20: 1180-1186.
20. Sokolow M, Lyon TP,. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161-186.
21. Prineas RJ, Crow RS, Blackburn H,. The Minnesota Code Manual of Electrocardiographic Findings: Standard and Procedures for Measurement and Classification. Bristol, England, John Wright PSG Inc., 1982, pp. 111-130, 227.
22. Bristow MR, Saxon LA, Boehmer J, et al., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
23. Cleland JG, Daubert JC, Erdmann E, et al., The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
24. Moss AJ, Hall WJ, Cannom DS, et al., Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
25. Okin PM, Devereux RB, Harris KE, et al., Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med 2007; 147: 311-319.
26. Kannel WB, Gordon T, Offutt D,. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71: 89-105.
27. Kannel WB,. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75 (3A): 4-11.
28. Kannel WB, Dannenberg AL, Levy D,. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987; 60: 85I-93I.
29. Kannel WB, Gordon T, Castelli WP, et al., Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med 1970; 72: 813-822.
30. Okin PM, Devereux RB, Jern S, et al., Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events: The LIFE Study. JAMA 2004; 292: 2343-2349.
31. Okin PM, Wachtell K, Devereux RB, et al., Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006; 296: 1242-1248.
32. Okin PM, Devereux RB, Harris KE, et al., In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: The LIFE Study. Hypertension 2007; 50: 984-990.
33. Ishikawa J, Ishikawa S, Kabutoya T, et al., Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension 2009; 53: 28-34.
34. Rudolph A, Abdel-Aty H, Bohl S, et al., Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy to remodeling. J Am Coll Cardiol 2009; 53: 284-291.
35. Ellims AH, Iles LM, Ling LH, et al., Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 2012; 14: 76.
36. Pearlman AS, Ryan T, Picard MH, et al., Evolving trends in the use of echocardiography: A study of Medicare beneficiaries. J Am Coll Cardiol 2007; 49: 2283-2291.
37. Patel MR, Spertus JA, Brindis RG, et al., ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol 2005; 46: 1606-1613.
38. Parekh N, Maisel AS,. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Curr Opin Cardiol 2009; 24: 155-160.
39. Lubien E, DeMaria A, Krishnaswamy P, et al., Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
40. Mak GS, DeMaria A, Clopton P, et al., Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: Comparison with tissue Doppler imaging recordings. Am Heart J 2004; 148: 895-902.
41. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al., Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: A community-based study. Circulation 2004; 109: 3176-3181.